Patent · US Active

Continuous transdermal monitoring system and method

US9339236B2 · kind B2 · utility

35Cited by
10References
15Claims
0Family size

Inventors

Key dates

Filing dateDec 9, 2014
Grant dateMay 17, 2016
Priority date
Expiry dateDec 9, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B2562/0219
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Various embodiments of methods and systems for continuous transdermal monitoring (“CTM”) are disclosed. One exemplary embodiment of a continuous transdermal monitoring system comprises a sensor package. The sensor package may include a pulse oximetry sensor having a plurality of light detectors arranged as an array. One exemplary method for continuous transdermal monitoring begins by positioning a pulse oximetry sensor system, similar to the system described immediately above, adjacent to a target tissue segment. Then, the method continues by detecting a light reflected by the target tissue segment. Then, the method continues by transmitting a pulse oximetry reading(s), based at least in part on the light reflected by the target tissue segment, of the target tissue segment. Then, the method continues by analyzing the pulse oximetry reading(s). Then, the method continues by assessing the accuracy of the pulse oximetry reading from the first light detector relative to the pulse oximetry reading from the second light detector.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.